Literature DB >> 28428224

Familial Hypercholesterolemia and Type 2 Diabetes in the Old Order Amish.

Huichun Xu1, Kathleen A Ryan1, Thomas J Jaworek1, Lorraine Southam2,3, Jeffrey G Reid4, John D Overton4, Aris Baras4, Marja K Puurunen4, Eleftheria Zeggini3, Simeon I Taylor1, Alan R Shuldiner4, Braxton D Mitchell5,6.   

Abstract

Alleles associated with lower levels of LDL cholesterol (LDL-C) have recently been associated with an increased risk of type 2 diabetes (T2D), highlighting the complex relationship between LDL-C and diabetes. This observation begs the question of whether LDL-C-raising alleles are associated with a decreased risk of T2D. This issue was recently addressed in a large familial hypercholesterolemia (FH) screening study, which reported a lower prevalence of self-reported diabetes in FH subjects than in age-matched relatives without FH. To extend this observation, we tested the association of FH with diabetes status and glycemia in a large Amish population enriched for the FH-associated APOB R3527Q variant that included 640 APOB R3527Q carriers and 4,683 noncarriers. Each copy of the R3527Q T allele was associated with a 74.9 mg/dL increase in LDL-C. There was little difference in T2D prevalence between subjects with (5.2%) and without (4.5%) the R3527Q allele (P = 0.23), and there was no association between R3527Q variant and impaired fasting glucose, fasting glucose or insulin, or oral glucose tolerance test-derived measures. Our data provide no evidence supporting an association between the APOB R3527Q variant and T2D or glycemia and highlight the asymmetry of the LDL-C-T2D relationship and/or the gene/variant-dependent specificity of the LDL-C-T2D association.
© 2017 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28428224      PMCID: PMC5482078          DOI: 10.2337/db17-0173

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  19 in total

1.  Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study.

Authors:  Frederick E Dewey; Michael F Murray; John D Overton; Lukas Habegger; Joseph B Leader; Samantha N Fetterolf; Colm O'Dushlaine; Cristopher V Van Hout; Jeffrey Staples; Claudia Gonzaga-Jauregui; Raghu Metpally; Sarah A Pendergrass; Monica A Giovanni; H Lester Kirchner; Suganthi Balasubramanian; Noura S Abul-Husn; Dustin N Hartzel; Daniel R Lavage; Korey A Kost; Jonathan S Packer; Alexander E Lopez; John Penn; Semanti Mukherjee; Nehal Gosalia; Manoj Kanagaraj; Alexander H Li; Lyndon J Mitnaul; Lance J Adams; Thomas N Person; Kavita Praveen; Anthony Marcketta; Matthew S Lebo; Christina A Austin-Tse; Heather M Mason-Suares; Shannon Bruse; Scott Mellis; Robert Phillips; Neil Stahl; Andrew Murphy; Aris Economides; Kimberly A Skelding; Christopher D Still; James R Elmore; Ingrid B Borecki; George D Yancopoulos; F Daniel Davis; William A Faucett; Omri Gottesman; Marylyn D Ritchie; Alan R Shuldiner; Jeffrey G Reid; David H Ledbetter; Aris Baras; David J Carey
Journal:  Science       Date:  2016-12-23       Impact factor: 47.728

2.  Familial defective apolipoprotein B-100 and increased low-density lipoprotein cholesterol and coronary artery calcification in the old order amish.

Authors:  Haiqing Shen; Coleen M Damcott; Evadnie Rampersaud; Toni I Pollin; Richard B Horenstein; Patrick F McArdle; Patricia A Peyser; Lawrence F Bielak; Wendy S Post; Yen-Pei C Chang; Kathleen A Ryan; Michael Miller; John A Rumberger; Patrick F Sheedy; John Shelton; Jeffrey R O'Connell; Alan R Shuldiner; Braxton D Mitchell
Journal:  Arch Intern Med       Date:  2010-11-08

3.  Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100.

Authors:  J Boren; I Lee; W Zhu; K Arnold; S Taylor; T L Innerarity
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

4.  Using Genetic Variants to Assess the Relationship Between Circulating Lipids and Type 2 Diabetes.

Authors:  Tove Fall; Weijia Xie; Wenny Poon; Hanieh Yaghootkar; Reedik Mägi; Joshua W Knowles; Valeriya Lyssenko; Michael Weedon; Timothy M Frayling; Erik Ingelsson
Journal:  Diabetes       Date:  2015-05-06       Impact factor: 9.461

5.  The Pharmacogenomics of Anti-Platelet Intervention (PAPI) Study: Variation in Platelet Response to Clopidogrel and Aspirin.

Authors:  Laura M Bozzi; Braxton D Mitchell; Joshua P Lewis; Kathy A Ryan; William R Herzog; Jeffrey R O'Connell; Richard B Horenstein; Alan R Shuldiner; Laura M Yerges-Armstrong
Journal:  Curr Vasc Pharmacol       Date:  2016       Impact factor: 2.719

6.  Reduced incidence of hip fracture in the Old Order Amish.

Authors:  Elizabeth A Streeten; Daniel J McBride; Amy L Lodge; Toni I Pollin; David G Stinchcomb; Richa Agarwala; Alejandro A Schäffer; Jay R Shapiro; Alan R Shuldiner; Braxton D Mitchell
Journal:  J Bone Miner Res       Date:  2003-12-16       Impact factor: 6.741

7.  Association Between Low-Density Lipoprotein Cholesterol-Lowering Genetic Variants and Risk of Type 2 Diabetes: A Meta-analysis.

Authors:  Robert A Scott; Nicholas J Wareham; Luca A Lotta; Stephen J Sharp; Stephen Burgess; John R B Perry; Isobel D Stewart; Sara M Willems; Jian'an Luan; Eva Ardanaz; Larraitz Arriola; Beverley Balkau; Heiner Boeing; Panos Deloukas; Nita G Forouhi; Paul W Franks; Sara Grioni; Rudolf Kaaks; Timothy J Key; Carmen Navarro; Peter M Nilsson; Kim Overvad; Domenico Palli; Salvatore Panico; Jose-Ramón Quirós; Elio Riboli; Olov Rolandsson; Carlotta Sacerdote; Elena C Salamanca; Nadia Slimani; Annemieke Mw Spijkerman; Anne Tjonneland; Rosario Tumino; Daphne L van der A; Yvonne T van der Schouw; Mark I McCarthy; Inês Barroso; Stephen O'Rahilly; David B Savage; Naveed Sattar; Claudia Langenberg
Journal:  JAMA       Date:  2016-10-04       Impact factor: 56.272

8.  Association of Lipid Fractions With Risks for Coronary Artery Disease and Diabetes.

Authors:  Jon White; Daniel I Swerdlow; David Preiss; Zammy Fairhurst-Hunter; Brendan J Keating; Folkert W Asselbergs; Naveed Sattar; Steve E Humphries; Aroon D Hingorani; Michael V Holmes
Journal:  JAMA Cardiol       Date:  2016-09-01       Impact factor: 14.676

9.  Founder mutations in the Netherlands: geographical distribution of the most prevalent mutations in the low-density lipoprotein receptor and apolipoprotein B genes.

Authors:  D M Kusters; R Huijgen; J C Defesche; M N Vissers; I Kindt; B A Hutten; J J P Kastelein
Journal:  Neth Heart J       Date:  2011-01-27       Impact factor: 2.380

10.  Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes.

Authors:  Brian A Ference; Jennifer G Robinson; Robert D Brook; Alberico L Catapano; M John Chapman; David R Neff; Szilard Voros; Robert P Giugliano; George Davey Smith; Sergio Fazio; Marc S Sabatine
Journal:  N Engl J Med       Date:  2016-12-01       Impact factor: 91.245

View more
  11 in total

Review 1.  Unexplained reciprocal regulation of diabetes and lipoproteins.

Authors:  Sei Higuchi; M Concepción Izquierdo; Rebecca A Haeusler
Journal:  Curr Opin Lipidol       Date:  2018-06       Impact factor: 4.776

2.  Genetic pleiotropy between mood disorders, metabolic, and endocrine traits in a multigenerational pedigree.

Authors:  Rachel L Kember; Liping Hou; Xiao Ji; Lars H Andersen; Arpita Ghorai; Lisa N Estrella; Laura Almasy; Francis J McMahon; Christopher Brown; Maja Bućan
Journal:  Transl Psychiatry       Date:  2018-10-12       Impact factor: 6.222

3.  ATAC-seq reveals alterations in open chromatin in pancreatic islets from subjects with type 2 diabetes.

Authors:  Madhusudhan Bysani; Rasmus Agren; Cajsa Davegårdh; Petr Volkov; Tina Rönn; Per Unneberg; Karl Bacos; Charlotte Ling
Journal:  Sci Rep       Date:  2019-05-23       Impact factor: 4.379

Review 4.  Diabetes and Familial Hypercholesterolemia: Interplay between Lipid and Glucose Metabolism.

Authors:  Ana M González-Lleó; Rosa María Sánchez-Hernández; Mauro Boronat; Ana M Wägner
Journal:  Nutrients       Date:  2022-04-03       Impact factor: 5.717

5.  Identification of genetic variants related to metabolic syndrome by next-generation sequencing.

Authors:  Sanghoo Lee; Seol-A Kim; Jeonghoon Hong; Yejin Kim; Gayeon Hong; SaeYun Baik; Kyeonghwan Choi; Mi-Kyeong Lee; Kyoung-Ryul Lee
Journal:  Diabetol Metab Syndr       Date:  2022-08-23       Impact factor: 5.395

6.  Hepatocyte Rap1a contributes to obesity- and statin-associated hyperglycemia.

Authors:  Yating Wang; Stefano Spolitu; John A Zadroga; Amesh K Sarecha; Lale Ozcan
Journal:  Cell Rep       Date:  2022-08-23       Impact factor: 9.995

7.  Common and Rare PCSK9 Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.

Authors:  Lung-An Hsu; Ming-Sheng Teng; Semon Wu; Hsin-Hua Chou; Yu-Lin Ko
Journal:  Int J Mol Sci       Date:  2022-09-08       Impact factor: 6.208

Review 8.  Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract.

Authors:  François Mach; Kausik K Ray; Olov Wiklund; Alberto Corsini; Alberico L Catapano; Eric Bruckert; Guy De Backer; Robert A Hegele; G Kees Hovingh; Terry A Jacobson; Ronald M Krauss; Ulrich Laufs; Lawrence A Leiter; Winfried März; Børge G Nordestgaard; Frederick J Raal; Michael Roden; Raul D Santos; Evan A Stein; Erik S Stroes; Paul D Thompson; Lale Tokgözoglu; Georgirene D Vladutiu; Baris Gencer; Jane K Stock; Henry N Ginsberg; M John Chapman
Journal:  Eur Heart J       Date:  2018-07-14       Impact factor: 29.983

9.  Familial Hypercholesterolaemia in a Bulgarian Population of Patients with Dyslipidaemia and Diabetes: An Observational Study.

Authors:  Tsvetalina Tankova; Atanaska Elenkova; Ralitsa Robeva; Roumyana Dimova; Anna-Maria Borissova; Adrian Olszewski; Vasil Lachev; Reneta Petkova
Journal:  Diabetes Ther       Date:  2020-01-02       Impact factor: 2.945

Review 10.  Prioritising Risk Factors for Type 2 Diabetes: Causal Inference through Genetic Approaches.

Authors:  Laura B L Wittemans; Luca A Lotta; Claudia Langenberg
Journal:  Curr Diab Rep       Date:  2018-05-19       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.